Replies to post #1529 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

The EDP-305 phase-1/1b data are everything investors could have wanted at this stage, IMO.

The phase-2 trial in NASH patients, which begins in 2018, will be the first test of efficacy.